Zobrazeno 1 - 3
of 3
pro vyhledávání: '"35"'
Autor:
Zancong Shen, Michael Gillen, Amy Yamamoto, Jesse Hall, Xiaohong Yan, Masanari Shiramoto, Yasushi Ito, Sha Liu
Publikováno v:
Rheumatology (Oxford, England)
Objectives Verinurad (RDEA3170) is a high-affinity inhibitor of the URAT1 transporter in clinical development for treating gout and asymptomatic hyperuricaemia. The aim of this Phase 2a, randomized, open-label study was to investigate the multiple-do
Publikováno v:
Rheumatology (Oxford, England)
Objectives. Contralateral responses to unilateral stimuli have been well described in animal models. These range from central sensitization to peripheral inflammatory responses. Our aim was to test for contralateral responses following unilateral int
Autor:
Fabio M. Iwamoto, Lauren E. Abrey, Wei-Ting Zhang, Susan M. Chang, Howard A. Fine, H. Ian Robins, Michael D. Prados, Minesh P. Mehta, Lisa M. DeAngelis, Kathleen R. Lamborn, Nicholas Butowski
The objective of this phase II single-arm study was to evaluate the efficacy and safety of pazopanib, a multi-targeted tyrosine kinase inhibitor, against vascular endothelial growth factor receptor (VEGFR)-1, -2, and -3, platelet-derived growth facto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adb622f62cc575442411bdfb2a867e40
https://europepmc.org/articles/PMC2940686/
https://europepmc.org/articles/PMC2940686/